Scientific Sessions 2024  /  Too Far Gone? Revascularization of Multivessel CAD in Severe Cardiomyopathy  /  Debate: PCI is the Optimal Modality for Management of Multivessel CAD and Severe Cardiomyopathy
Logo

American Heart Association

  2
  0

Final ID:

Debate: PCI is the Optimal Modality for Management of Multivessel CAD and Severe Cardiomyopathy

  • Mcentegart, Margaret  ( ColumbiaUniversityMedicalCenter , New York , New York , United States )
  • Perera, Divaka  ( St. Thomas' Hospital , London , United Kingdom )
    • Author Disclosures:
    Margaret McEntegart: DO have relevant financial relationships ; Consultant:Boston Scientific :Active (exists now) ; Consultant:Biosensors:Past (completed) ; Speaker:Medtronic:Past (completed) ; Speaker:Asahi:Past (completed) ; Consultant:Shockwave Medical:Active (exists now) | Divaka Perera: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Too Far Gone? Revascularization of Multivessel CAD in Severe Cardiomyopathy

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Advances in Imaging for Viability Assessment to Aid in Treatment Planning

Woodard Pamela, Jacobs Jill, Ordovas Karen

Too Much Too Late: When to Forego Revascularization in Favor of Advanced Heart Failure Therapies

Pirlamarla Preethi, Lewis Eldrin, Uriel Nir

You have to be authorized to contact abstract author. Please, Login
Not Available